EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure

Fizza Mushtaq, Syed Mohsin Raza, Adeel Ahmad, Hina Aslam, Atiqa Adeel, Sidrah Saleem, Irfan Ahmad iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0293194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Fizza Mushtaq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical and Allied Health Sciences, University of Health Sciences, Lahore, Pakistan. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis stands as a prominent cause of mortality in developing countries. The treatment of tuberculosis involves a complex procedure requiring the administration of a panel of at least four antimicrobial drugs for the duration of six months. The occurrence of treatment failure after the completion of a standard treatment course presents a serious medical problem. The purpose of this study was to evaluate antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure. Additionally, it aimed to evaluate the effectiveness of second line drugs such as amikacin, linezolid, moxifloxacin, and the efflux pump inhibitor verapamil against M . tuberculosis isolates associated with treatment failure. We monitored 1200 tuberculosis patients who visited TB centres in Lahore and found that 64 of them were not cured after six months of treatment. Among the M . tuberculosis isolates recovered from the sputum of these 64 patients, 46 (71.9%) isolates were simultaneously resistant to rifampicin and isoniazid (MDR), and 30 (46.9%) isolates were resistant to pyrazinamide, Resistance to amikacin was detected in 17 (26,5%) isolates whereas resistance to moxifloxacin and linezolid was detected in 1 (1.5%) and 2 (3.1%) isolates respectively. Among MDR isolates, the additional resistance to pyrazinamide, amikacin, and linezolid was detected in 15(23.4%), 4(2.6%) and 1(1.56%) isolates respectively. One isolate simultaneously resistant to rifampicin, isoniazid, amikacin, pyrazinamide, and linezolid was also identified. In our investigations, the most frequently mutated amino acid in the treatment failure group was Serine 315 in katG . Three novel mutations were detected at codons 99, 149 and 154 in pncA which were associated with pyrazinamide resistance. The effect of verapamil on the minimum inhibitory concentration of isoniazid and rifampicin was observed in drug susceptible isolates but not in drug resistant isolates. Rifampicin and isoniazid enhanced the transcription of the efflux pump gene r v1258 in drug susceptible isolates collected from the treatment failure patients. Our findings emphasize a high prevalence of MDR isolates linked primarily to drug exposure. Moreover, the use of amikacin as a second line drug may not be the most suitable choice in such cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantHumansAntitubercular AgentsIsoniazidPyrazinamideRifampinLinezolidAmikacinMoxifloxacinMicrobial Sensitivity TestsVerapamilMutation

Substanzen

Antitubercular AgentsIsoniazidPyrazinamideRifampinLinezolidAmikacinMoxifloxacinVerapamil

Autor:innen und Institutionen

  • Institute of Biomedical and Allied Health Sciences, University of Health Sciences, Lahore, Pakistan.
  • Department of Molecular Biology and Umeå Centre for Microbial Research (UCMR), Umeå University, Umeå, Sweden.
  • Department of Microbiology, University of Health Sciences, Lahore, Pakistan.

ORCID-Profile: Irfan Ahmad

Zitieren

APA

Mushtaq, F., Raza, S. M., Ahmad, A., Aslam, H., Adeel, A., Saleem, S., & Ahmad, I. (2023). Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure. PLOS ONE. https://doi.org/10.1371/journal.pone.0293194

Vancouver

Mushtaq F, Raza SM, Ahmad A, Aslam H, Adeel A, Saleem S, et al. Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure. PLOS ONE. 2023. doi:10.1371/journal.pone.0293194

BibTeX
@article{Mushtaq2023,
  author = {Mushtaq, Fizza and Raza, Syed Mohsin and Ahmad, Adeel and Aslam, Hina and Adeel, Atiqa and Saleem, Sidrah and Ahmad, Irfan},
  title = {Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0293194}
}
Kostenlos starten →